MATA NATHAN L. (Chief Scientific Officer) sold 6.0% of their position (1K shares) of BELITE BIO, INC on the open market
Open‑market sale worth $168.3K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 5 sales
Filed: 4/16/2026ACC: 0001193125-26-159036
Officer· Chief Scientific Officer
Since Mar 2026
-1K
Net shares
Net seller
$168.3K
Total sold
5
Open market trades
0B · 5S
5
Total transactions
1K disposed
Non-Derivative Transactions5
American depositary share
Direct
Shares
−383.00
Price / share
$167.58
Trade value
$64.18K
% of position
2.3%
4/15/2026
16.67K→16.28K
American depositary share
Direct
Shares
−537.00
Price / share
$168.64
Trade value
$90.56K
% of position
3.3%
4/15/2026
16.28K→15.75K
American depositary share
Direct
Shares
−68.00
Price / share
$169.15
Trade value
$11.50K
% of position
0.4%
4/15/2026
15.75K→15.68K
American depositary share
Direct
Shares
−8.00
Price / share
$170.76
Trade value
$1.37K
% of position
0.1%
4/15/2026
15.68K→15.67K
American depositary share
Direct
Shares
−4.00
Price / share
$171.19
Trade value
$684.76
% of position
0.0%
4/15/2026
15.67K→15.67K
Total
Net shares
−1K
Net value
-$168.30K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| American depositary share Direct | 4/15/2026 | S · Sale | −383.00 | $167.58 | $64.18K | 2.3% | 16.67K | 16.28K |
| American depositary share Direct | 4/15/2026 | S · Sale | −537.00 | $168.64 | $90.56K | 3.3% | 16.28K | 15.75K |
| American depositary share Direct | 4/15/2026 | S · Sale | −68.00 | $169.15 | $11.50K | 0.4% | 15.75K | 15.68K |
| American depositary share Direct | 4/15/2026 | S · Sale | −8.00 | $170.76 | $1.37K | 0.1% | 15.68K | 15.67K |
| American depositary share Direct | 4/15/2026 | S · Sale | −4.00 | $171.19 | $684.76 | 0.0% | 15.67K | 15.67K |
| Total | −1K | -$168.30K | ||||||
Derivative Transactions0
No derivative transactions reported